Form 4: Guardian Pharmacy CFO Converts Shares, Plans Transfers

Guardian Pharmacy Services CFO David K. Morris converted Class B shares to Class A and disclosed future share transfers related to a divorce settlement.

Summary

• David K. Morris, Director, Executive Vice President, and Chief Financial Officer of Guardian Pharmacy Services, Inc., reported a change in beneficial ownership.
• On September 27, 2025, 641,869 shares of Class B common stock automatically converted into an equal number of Class A common stock on a one-for-one basis.
• Following this transaction, Mr. Morris beneficially owns 856,364 shares of Class A common stock directly.
• He also beneficially owns 1,283,739 shares of Class B common stock, which are convertible into Class A common stock.
• A domestic relations order (DRO) from September 2025 mandates the transfer of 422,989 Class A common shares to his former spouse by November 11, 2025.
• Additionally, the DRO requires the transfer of 641,870 Class A common shares (issuable upon future Class B conversions) to his former spouse between March 28, 2026, and November 11, 2026.

Sentiment

Score: 5

Explanation: The filing reports a mandatory share conversion and transfers due to a personal legal settlement, which is a neutral event regarding the company's operational performance or strategic direction.

Negatives

• The reporting person will transfer a significant number of Class A shares (totaling 1,064,859 shares) to a former spouse over time due to a domestic relations order, reducing his direct beneficial ownership.

Risks

• A reduction in the beneficial ownership of a key executive (CFO) could be perceived negatively by some investors, although it is due to a personal legal settlement rather than a voluntary sale.

Future Outlook

Shares of Class B common stock will automatically convert into Class A common stock on a one-for-one basis in substantially equal tranches on March 28, 2026, and September 27, 2026. Additionally, a total of 1,064,859 Class A shares are scheduled for transfer to a former spouse by November 11, 2026, as per a domestic relations order.

Management Comments

• Shares of Class B common stock automatically convert into shares of Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026, and September 27, 2026.
• Pursuant to a September 2025 domestic relations order, 422,989 Class A common shares will be transferred to a former spouse by November 11, 2025.
• Pursuant to the domestic relations order, 641,870 Class A common shares (issuable upon conversion of Class B shares) will be transferred to a former spouse during the period from March 28, 2026, through November 11, 2026.

Industry Context

This filing details an insider's share conversion and planned transfers, which is a company-specific event and does not directly reflect broader industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: The filing indicates a future reduction in the beneficial ownership of a key executive, which could be a minor factor in assessing insider alignment, though it stems from a personal legal obligation.

Next Steps

• Further tranches of Class B common stock will convert to Class A common stock on March 28, 2026, and September 27, 2026.
• Transfer of 422,989 Class A common shares to a former spouse by November 11, 2025.
• Transfer of 641,870 Class A common shares to a former spouse between March 28, 2026, and November 11, 2026.

Key Dates

Keywords

Guardian Pharmacy Services, GRDN, Form 4, Insider Transaction, Share Conversion, Class A Common Stock, Class B Common Stock, David K. Morris, CFO, Beneficial Ownership